10.19 USD
▼-0.53-4.94%
盘后 10.07 -1.18%
2026-09-15
市值
$2.17B
市盈率
—
EPS
-1.41
股息率
—
52 周区间
6.23 – 16.44
成交量
2.10M
Beta
0.97
目标价
27.09
52W 低 6.2352W 高 16.44
价格走势
公司简介
Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing AXPAXLI, an axitinib intravitreal hydrogel that is in phase 3 clinical trials for the treatment of ...